Imunon, Inc. Treasury Stock, Value
Imunon, Inc. (IMNN) had Treasury Stock, Value of $85.19 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:TreasuryStockValue · last filed 2026-08-11
- 2026-06-30: Treasury Stock, Value $85.19K.
- 2026-03-31: Treasury Stock, Value $85.19K.
- 2025-12-31: Treasury Stock, Value $85.19K.
- 2025-09-30: Treasury Stock, Value $85.19K.
| Period end | Treasury Stock, Value |
|---|---|
| 2026-06-30 | $85.19K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $85.19K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $85.19K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $85.19K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $85.19K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $85.19K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $85.19K 10-K · filed 2026-03-31 |
| 2024-09-30 | $85.19K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $85.19K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $85.19K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $85.19K 10-K · filed 2025-02-27 |
| 2023-09-30 | $85.19K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $85.19K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $85.19K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $85.19K 10-K · filed 2024-03-28 |
| 2022-09-30 | $85.19K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $85.19K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $85.19K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $85.19K 10-K · filed 2023-03-30 |
| 2021-09-30 | $85.19K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $85.19K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $85.19K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $85.19K 10-K · filed 2022-03-31 |
| 2020-09-30 | $85.19K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $85.19K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $85.19K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $85.19K 10-K · filed 2021-03-19 |
| 2019-09-30 | $85.19K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $85.19K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $85.19K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $85.19K 10-K · filed 2020-03-25 |
| 2018-09-30 | $85.19K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $85.19K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $85.19K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $85.19K 10-K · filed 2019-03-29 |
| 2017-09-30 | $85.19K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $85.19K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $85.19K 10-Q · filed 2017-05-12 |
| 2016-12-31 | $85.19K 10-K · filed 2018-03-27 |
| 2016-09-30 | $417.29K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $963.83K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $1.18M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $1.38M 10-K · filed 2017-03-24 |
| 2015-09-30 | $1.52M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $1.69M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $1.86M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $2.06M 10-K · filed 2016-03-30 |
| 2014-09-30 | $2.20M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $2.26M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $2.38M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $2.42M 10-K · filed 2015-03-12 |
| 2013-09-30 | $2.47M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $2.68M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $2.68M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $2.69M 10-K · filed 2014-03-13 |
| 2012-09-30 | $2.70M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $2.72M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $2.76M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $2.88M 10-K · filed 2013-03-18 |
| 2011-09-30 | $2.91M 10-Q · filed 2011-11-10 |
| 2011-06-30 | $3.02M 10-Q · filed 2011-08-09 |
| 2010-12-31 | $3.08M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |